BioTek Expands in the United Kingdom
News Jun 05, 2015
BioTek Instruments, Inc. expands their ongoing investment in the European microplate-based technology market with the opening of their new UK Office in Swindon. Mr. Dominic Herring, previously BioTek’s Business and Development Manager with BioTek Singapore, was named General Manager. The new office will focus on bringing enhanced applications and technical support to current and future customers in the United Kingdom.
"The UK’s biotechnology and life scientific sectors are growing; supported by the government’s focus and investment," noted Dominic Herring, BioTek’s UK General Manager. "Our new and expanded direct office in Swindon will allow us to provide local, comprehensive and immediate sales, applications and service support to our rapidly increasing customer base in a market that continues to demonstrate high quality scientific research." BioTek UK is now fully functional and will house administration, sales, service, technical support, training and a complete supplies inventory.
"The establishment of our new BioTek UK Office will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing local service and applications support, our customers in the UK will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced satisfaction for our customers."
Researchers have found that two structurally similar compounds – deguelin and rotenone, naturally occurring pesticides produced by many plant species – interfered with melanoma cancer cells’ metabolism. Further testing with deguelin showed that it inhibited oxygen consumption in the cells’ mitochondria, effectively starving the cells of energy.READ MORE